Zdrowie i gospodarka · 26/03/2008
FDA Releases Draft Guidance on Genotoxicity Testing for Pharmaceuticals
The FDA has made available a draft guidance document, S2(R1), which aims to standardize genotoxicity testing for pharmaceuticals intended for human use, ultimately enhancing patient safety and reducing animal testing.
Source: Federal Register — Food and Drug AdministrationOpen original release →